| Jan 23, 2026 |
Jan 26, 2026 |
Oien Jessica
|
Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 23, 2026 |
Jan 26, 2026 |
Hassig Christian
|
Chief Scientific Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 23, 2026 |
Jan 26, 2026 |
Doebele Robert
|
Chief Medical Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 23, 2026 |
Jan 26, 2026 |
Hornby Zachary
|
CEO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 23, 2026 |
Jan 26, 2026 |
HINKLE DAVID A
|
Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 23, 2025 |
Jun 23, 2025 |
Brennan Christine
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 23, 2025 |
Jun 23, 2025 |
Christensen James
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 23, 2025 |
Jun 23, 2025 |
Lew Jennifer
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 23, 2025 |
Jun 23, 2025 |
Lim Jonathan E
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 23, 2025 |
Jun 23, 2025 |
Burow Kristina
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 23, 2025 |
Jun 23, 2025 |
Whiting Nancy
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Feb 3, 2025 |
Feb 3, 2025 |
Doebele Robert
|
Chief Medical Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Feb 3, 2025 |
Doebele Robert
|
Chief Medical Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 22, 2025 |
Jan 23, 2025 |
HINKLE DAVID A
|
Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 22, 2025 |
Jan 23, 2025 |
Hassig Christian
|
Chief Scientific Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 22, 2025 |
Jan 23, 2025 |
Hornby Zachary
|
CEO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 22, 2025 |
Jan 23, 2025 |
Oien Jessica
|
Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Oct 15, 2024 |
HINKLE DAVID A
|
Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Aug 19, 2024 |
Aug 20, 2024 |
Hassig Christian
|
Chief Scientific Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Aug 19, 2024 |
Aug 20, 2024 |
Oien Jessica
|
Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Aug 19, 2024 |
Aug 20, 2024 |
Hornby Zachary
|
CEO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Aug 19, 2024 |
Aug 20, 2024 |
Abdollahian Neil
|
Chief Business Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Aug 19, 2024 |
Aug 20, 2024 |
Wagner Klaus W.
|
Chief Medical Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Aug 19, 2024 |
Aug 20, 2024 |
Rubin Jami
|
CFO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 20, 2024 |
Jun 20, 2024 |
Lim Jonathan E
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Apr 2, 2024 |
Apr 4, 2024 |
Burow Kristina
|
Director |
Buy |
100.0
|
+200,000
|
12.01%
|
✗
|
$3.2M |
| Apr 2, 2024 |
Apr 4, 2024 |
Lim Jonathan E
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Apr 2, 2024 |
Apr 4, 2024 |
CRANDELL KEITH
|
10% Owner |
Buy |
100.0
|
+200,000
|
12.01%
|
✗
|
$3.2M |
| Apr 2, 2024 |
Apr 4, 2024 |
ARCH Venture Fund IX, L.P.
|
10% Owner |
Buy |
100.0
|
+200,000
|
12.01%
|
✗
|
$3.2M |
| Apr 2, 2024 |
Apr 4, 2024 |
RA CAPITAL MANAGEMENT, L.P.
|
10% Owner |
Buy |
100.0
|
+312,500
|
16.73%
|
✗
|
$5M |
| Apr 2, 2024 |
Apr 2, 2024 |
Wellington Biomedical Innovation Master Investors (Cayman) I L.P.
|
10% Owner |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Mar 27, 2024 |
Mar 29, 2024 |
Lim Jonathan E
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Mar 27, 2024 |
Mar 29, 2024 |
Lew Jennifer
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Mar 27, 2024 |
Mar 29, 2024 |
Brennan Christine
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Mar 27, 2024 |
Mar 29, 2024 |
Burow Kristina
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Mar 27, 2024 |
Mar 29, 2024 |
Rubin Jami
|
CFO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Mar 27, 2024 |
Mar 29, 2024 |
Hornby Zachary
|
CEO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Mar 27, 2024 |
Mar 29, 2024 |
Christensen James
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Mar 27, 2024 |
Mar 29, 2024 |
Oien Jessica
|
Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Mar 27, 2024 |
Mar 29, 2024 |
Abdollahian Neil
|
Chief Business Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Mar 27, 2024 |
Mar 29, 2024 |
Wagner Klaus W.
|
Chief Medical Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Mar 27, 2024 |
Mar 29, 2024 |
Whiting Nancy
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Mar 27, 2024 |
Mar 29, 2024 |
Hassig Christian
|
Chief Scientific Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Mar 27, 2024 |
Wellington Biomedical Innovation Master Investors (Cayman) I L.P.
|
10% Owner |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Mar 27, 2024 |
RA CAPITAL MANAGEMENT, L.P.
|
10% Owner |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Mar 27, 2024 |
Abdollahian Neil
|
Chief Business Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Mar 27, 2024 |
Brennan Christine
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Mar 27, 2024 |
Burow Kristina
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Mar 27, 2024 |
Christensen James
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Mar 27, 2024 |
Hassig Christian
|
Chief Scientific Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Mar 27, 2024 |
Lew Jennifer
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Mar 27, 2024 |
Hornby Zachary
|
CEO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Mar 27, 2024 |
Lim Jonathan E
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Mar 27, 2024 |
Rubin Jami
|
CFO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Mar 27, 2024 |
Oien Jessica
|
Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Mar 27, 2024 |
CRANDELL KEITH
|
10% Owner |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Mar 27, 2024 |
Wagner Klaus W.
|
Chief Medical Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Mar 27, 2024 |
ARCH Venture Fund IX, L.P.
|
10% Owner |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Mar 27, 2024 |
Whiting Nancy
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |